Introduction
The recognition and lysis of target cells by NK cells is complex and incompletely understood. Early observations showed that the loss of expression of class I molecules on tumor cells rendered these cells sensitive to NK lysis in vitro and NK cell-mediated rejection in vivo (1, 2) . As a result of these observations, Kä rre and Ljunggren proposed that NK cells formed a 'defense system geared to detect the deleted or reduced expression of self-MHC', the missing self-hypothesis (3) . This hypothesis has provided a mechanistic explanation of why NK cells kill certain class I-deficient target cells and why this killing is reversed upon transfection of the missing class I genes. Recent studies have helped to define the molecular basis for these observations. NK cells express inhibitory receptors that recognize specific MHC class I molecules (4, 5) . For example, in mice the NK inhibitory receptor CD94/NKG2 specifically recognizes Qa-1 b , whereas the Ly49 receptor family interacts with H-2K or H-2D (4, 5) . Thus, target cells that express low levels of MHC class I molecules do not engage inhibitory receptors, trigger activating NK cell receptors and are sensitive to NK lysis. In contrast, target cells that express high levels of MHC class I molecules engage the inhibitory receptors on NK cells and block NK cell-mediated killing.
The adenovirus (Ad) system is a well-documented, but poorly understood, exception to the inverse relationship between the expression of class I MHC molecules on target cells and susceptibility to NK cell lysis. The expression of the Ad serotype 2 or 5 (Ad2/5) E1A gene products following either infection, transfection or viral transformation sensitizes target cells of several different species (human, mouse, rat, hamster) to lysis by NK cells (6) (7) (8) (9) (10) (11) (12) . The ability of E1A to sensitize cells to NK cell killing is unrelated to the expression of class I molecules on target cells (9, (12) (13) (14) (15) . In fact, the expression of Ad5E1A gene products in E1A-transfected tumor cells or Ad2/5-transformed cells typically increases the surface expression of class I MHC molecules (12, 13, 15, 16) . Moreover, IFN-γ treatment, which increases the expression of MHC class I molecules on E1A-expressing target cells, does not confer resistance to NK cell killing (14, 17) . Thus, in cells that express E1A, sensitivity to NK cell lysis does not appear to be inhibited by expression of high levels of MHC class I molecules.
E1A induces novel biological effects in target cells that may explain the apparent inability of MHC class I molecules to regulate NK killing. Perforin/granzyme, Fas ligand (FasL), tumor necrosis factor (TNF)-α and TRAIL all contribute to NK cell lysis of target cells (18) (19) (20) (21) (22) (23) . In other model systems, reduction in the expression of class I molecules increases the susceptibility of cells to lysis by NK cells. However, decreases in MHC class I molecules do not change the intrinsic sensitivity of target cells to these NK killer effector mechanisms. In contrast, E1A expression sensitizes target cells to lysis by perforin/granzyme, FasL, TNF-α and TRAIL (10, 24) . Furthermore, perforin/granzyme, TNF-α and FasL contribute to the NK cell lysis of E1A-expressing cells (10,24,25 and unreported observations). Thus, the capacity of E1A to sensitize target cells to multiple killing mechanisms may over-ride the effects of MHC class I expression on the inhibition of NK cell activity. Alternatively, the capacity of MHC class I molecules to block the killing of E1A-expressing cells by NK cells could be masked in polyclonal populations of NK cells. Such polyclonal populations may include NK cells that are not subject to inhibition by the MHC class I molecules expressed by the target cells. Although a few studies used a clonal population of NK cells (10, 12) , none used clonal NK cell populations that uniformly expressed a NK cell inhibitory receptor known to interact with the particular MHC class I molecules present on the E1A-expressing target.
Recently, we demonstrated that transfection of the Ad5-E1A gene into the highly oncogenic, NK-resistant, tumor cell line, MCA-102 (H-2 b ), induced sensitivity to NK cell-mediated lysis. In nude mice, where rejection of tumor cells is mediated by NK cells, MCA-102-E1A tumor cells are~100-fold less tumorigenic than parental MCA102 tumor cells (15) . The levels of MHC class I molecules on the NK-sensitive, MCA-102-E1A cells were as much as 4-fold higher in comparison to the levels expressed on the parental, NK-resistant MCA-102 cells. Thus, the induction of NK cell sensitivity and the decreased tumorigenicity of MCA-102-E1A cells were not a consequence of a down-regulation of MHC class I molecules.
We adapted the MCA-102 model system to address whether expression of E1A gene products can undermine the ability of MHC class I molecules to deliver an inhibitory signal to NK cells. The killing of non-transfected and H-2D d -transfected MCA-102-E1A cells by the NK line RNK-Ly49A was examined. RNK-Ly49A is a rat NK cell line stably transfected with the inhibitory receptor, Ly49A, which recognizes H-2D d (26) . Prior studies showed that in C57BL/6 mice,~20% of NK cells express Ly49A (27) . Therefore, cytolysis assays were also performed using Ly49A ϩ , Ly49A -and polyclonal populations of NK cells isolated from the spleens of C57BL/6 nude mice. 
Methods

Cells and cell lines
The C57BL/6-derived, methylcholanthrene-induced sarcoma cell line, MCA-102, was provided by Dr Nicholas Restifo (National Institute of Health, Bethesda, MD) (28) . MCA-102-E1A cells were derived by transfection of the Ad5-EIA gene and express Ad5-E1A gene products (15) . (26) . The MCA-102 cell lines were maintained in DMEM supplemented with antibiotics, 15 mM glucose and 5% FCS, whereas the RNK lines were maintained in RPMI supplemented with antibiotics, 15 mM glucose and 10% FCS. Cell lines were periodically tested for contamination with Mycoplasma using the Mycotec assay (Bethesda Research Labs, Bethesda, MD) and were negative.
NK cell cytolysis assays
Six-hour, 51 Cr-release, NK cytolysis assays were performed as described (17). For antibody inhibition studies, effector cells were preincubated for 15 min at room temperature with intact antibody at a concentration of 10 µg/10 6 effectors prior to the addition of targets. Spleen cells from athymic nude C57BL/6 mice served as the source of polyclonal NK cells. In vivo depletions of NK cells in C57BL/6 nude mice were performed using the mAb, PK136, as described (31) . PK136 recognizes the NK1.1 antigen on NK cells (31) . The results shown represent the mean Ϯ SEM of at least four separate experiments. The mean percentage spontaneous release from all types of target cells was Ͻ20%.
Isolation of splenic-derived, IL-2 activated Ly49A ϩ and Ly49A -NK cells
IL-2-activated NK cells were prepared using fresh splenocytes from C57BL/6-nude mice as previously described (32).
Ly49A ϩ and Ly49A -IL-2-activated NK cells were isolated by panning as previously described (33) . Briefly, day 6 IL-2-activated NK cells were panned with the anti-Ly49A mAb, A1 (34) . The purity of the Ly49 -NK cell population was ensured by treatment with anti-Ly49A and rabbit anti-mouse Ig (Cappel, Malvern, PA), followed by rabbit complement (Cedarlane, Westbury, NY) for 1 h at 37°C. Ly49A -and Ly49A ϩ cell populations were then cultured overnight in complete RPMI supplemented with 1000 U/ml human IL-2 (NCI, Frederick, MD). Cells were washed extensively with HBSS with 3% FCS on day 7, replated and used for assays on day 9. This resulted in populations of NK cells that were Ͼ95% pure as assessed by their expression of NK1.1 and Ly49A by FACS.
Tumor induction studies
Congenitally athymic C57/BL6 mice were obtained from Jackson Laboratories (Bar Harbor, ME). Quantitative tumor induction studies were performed as previously described (35) . Briefly, mice (two animals per dilution) were injected s. 
Results
High level expression of H-2D d on MCA-102-E1A cells
Polyclonal NK cells, but not Ly49A ϩ NK cells, kill H-2D dexpressing MCA-102-E1A cells
We first examined whether H-2D d expression on MCA-102-E1A cells would inhibit killing by RNK-Ly49A; a rat NK cell line (RNK-1) stably transfected with the Ly49A gene. As shown in Fig. 2(A) , H-2D d expression on MCA-102-E1A cells did not inhibit killing by RNK cells that did not express Ly49A ( Fig. 2A) . Additionally, MCA-102-E1A-control cells were highly susceptible to killing by RNK-Ly49A cells (Fig. 2B) . In contrast, the expression of H-2D d on MCA-102-E1A cells inhibited killing by RNK-Ly49A cells to a level equivalent to the NK-resistant, MCA 102 cell line (Fig. 2B ). Thus, expression of H-2D d on MCA-102 cells induced an inhibitory signal to Ly49A-expressing RNK cells.
Next, we determined whether expression of H-2D d on MCA-102-E1A cells would inhibit killing by a polyclonal population of NK cells present in C57BL/6-splenocytes. As shown in Fig. 3 , there was equivalent lysis of MCA-102-E1A-control, MCA-102-E1A-D d -CL1 and MCA-102-E1A-D d -CL2 cells by polyclonal NK cells. In vivo depletion of NK cells in C57BL/6 mice using the antiNK.1 antibody PK136 abolished the lytic activity present in these splenocytes (Fig. 3) . Thus, NK cells mediated the spontaneous lytic activity present in nude mouse splenocytes. In C57BL/6 mice,~20% of NK cells express Ly49A, the inhibitory receptor that recognizes H-2D d (27, 33) . Therefore, it is possible that the inhibitory effect on NK cell lysis of H-2D d may not be detected using bulk populations of NK cells. However, other explanations are also possible. For example, the level of expression of Ly49A on splenic-derived, murine NK cells may be insufficient to block NK killing. Alternatively, the negative signal delivered by the Ly49A receptor cells may be insufficient to block signals delivered by activating receptors present on murine NK cells. To address these issues, we compared Ly49A expression on RNK-Ly49A and splenic-derived NK cells by FACS. Consistent with prior observations, we found that~22% of splenic-derived, NK1.1 ϩ NK cells expressed Ly49A (Fig. 4) . Furthermore, the level of Ly49A expressed on splenic-derived NK cells was greater than that expressed on RNK-Ly49A cells (Fig. 4) . Next, we directly tested the capacity of a purified population of Ly49A ϩ splenic-derived NK cells to kill control and H-2D d -expressing MCA-102-E1A cells. These experiments showed that H-2D d expression protected MCA-102-E1A cells from lysis by L49A ϩ , but not Ly49A -splenic-derived NK cells (Fig. 5) .
In summary, these data indicate that expression of H2D d on target cells inhibited the killing by RNK cells and splenicderived murine NK cells expressing L49A. However, the inhibitory effect of H-2D d expression on Ly49A ϩ NK cells was not detected in cytolysis assays using bulk populations of splenic-derived NK cells.
Control and H-2D d -expressing MCA-102-E1A cells have equivalent tumorigenicities in nude mice
Previous studies showed that the reduced tumorigenicity of MCA-102-E1A, compared to MCA-102 cells in C57BL/6-nude (Fig. 4) . These values were similar to the TPD 50 values we previously reported on parental, MCA-102-E1A cells in nude mice (15) . Therefore, the NK cell-mediated rejection of MCA-102-E1A tumor cells was not impaired by expression of H-2D d .
Discussion
Results from this study provide insight into prior observations on the relationship between expression of MHC class I molecules, tumorigenicity and NK sensitivity of Adtransformed and E1A-transfected tumor cells. Through the expression of the E1A and E1B oncogenes, Ad are able transform mammalian cells from many species, including man. The expression of the E1A oncogene derived from group C Ad (Ad serotypes 2 and 5) also sensitizes cells of several different species (human, mouse, rat and hamster) to NK cell lysis. Studies in rodent models indicate that low oncogenicity of group C Ad-transformed cells is, in part, due to the rejection of these cells by NK cells (9, 13, 15) . Similarly, the stable transfection of the Ad5-E1A gene into NK-resistant tumors reduces tumorigenicity as a result of enhanced NK cell-mediated rejection in vivo (15, 35) . However, neither the NK sensitivity nor tumorigenicity of E1A-expressing tumor cells correlated with the level of class I molecules expressed on these cells (6, 9, 13, 15, 37) .
Our results showed that H-2D d expresssion on MCA-102-E1A cells inhibited killing of target cells by Ly49A ϩ RNK cells (Fig. 2B) and Ly49A ϩ splenic-derived NK cells (Fig. 5) . In contrast, H-2D d expression did not measurably influence the killing of MCA-102-E1A cells by a polyclonal population of splenic-derived NK cells (Fig. 3) . Based on these results, the previously reported inability of increased class I molecule expression to block NK killing on E1A-expressing cells was likely due to the masking of this effect when polyclonal populations of NK cells were used. However, consistent with the previous studies, we found that the ability of NK cells to reject E1A-expressing tumor cells in vivo best correlated with in vitro cytolysis assays using polyclonal populations of NK cells present in the tumor challenge recipient (Figs 3 and 6) .
It is unclear how the expression of Ad2/5-E1A gene products results in the enhanced recognition and lysis by NK cells. However, the sensitivity of target cells to NK cell lysis is likely mediated by a balance of activating and inhibitory signals mediated by NK receptors. Thus, the induction of target cell susceptibility by E1A may be due to either an enhancement of the positive signal or suppression of an inhibitory signal transduced by NK cell receptors. Our data indicates that inhibitory signals are not altered by E1A expression. Therefore, we speculate that E1A expression increases target cell killing by enhancing positive signals through activating NK cell receptors.
Apart from Ly49A, H-2D d interacts with other Ly49 receptors that are non-clonally expressed on NK cells in C57BL/6 mice. These receptors include the inhibitory receptors Ly49G2 (expressed on 54% of NK cells) and Ly49C/I (expressed on 47% of NK cells), as well as the activating NK cell receptor Ly49D (expressed on 50% of NK cells) (27, 38) . Our data indicated that NK cells that co-expressed inhibitory and activating NK cell receptors could not lyse D d -expressing MCA-102-E1A cells. Thus, it is likely that in C57BL/6 nude mice a relatively small population of NK cells that do not express inhibitory receptors are sufficient to lyse large numbers of H-2D d -expressing, MCA-102-E1A cells. Furthermore, because H-2D d expression did not measurably affect the NK cell-dependent rejection of MCA-102-E1A cells, small numbers of uninhibited NK cells are also sufficient for the rejection of E1A-expressing tumor cells in vivo (Fig. 6) . These results illustrate the biological importance of having NK cells that express overlapping sets of inhibitory and excitatory receptors.
In summary, H-2D d expression on E1A-expressing MCA-102 cells inhibited killing by NK cells that expressed the Ly49A receptor. However, NK cell-dependent tumor rejection of MCA-102-E1A cells was not altered by H-2D d expression. Thus, in an immunocompetent animal, polyclonal populations of NK cells allow for heightened tumor immunosurveillance.
